tm logo

Monitor this mark

View On USPTO

LIFCINQUE
Live/Registered
REGISTERED

on 17 Dec 2024

Last Applicant/ Owned by

Sanofi

46 avenue de la Grande Armée

Paris

FR

75017

Serial Number

97706678 filed on 07th Dec 2022

Registration Number

7603473 registered on 17th Dec 2024

in the Principal Register

Correspondent Address

Lim, Karen

Lim, Karen FROSS ZELNICK LEHRMAN & ZISSU, P.C.

NEW YORK, NY 10036

United States

Filing Basis

No Filing Basis

Disclaimer

NO DATA

LIFCINQUE

Pharmaceutical preparations for the treatment of inflammation, cancer, multiple sclerosis, and autoimmune, inflammatory, and blood diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of inflammation, cancer, multiple sclerosis, and autoimmune, inflammatory, and blood diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97706678

Mark Type

No Service/Collective Mark

Attorney Docket Number

No SYN 2224068

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
17th Dec 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
17th Dec 2024REGISTERED-PRINCIPAL REGISTER
15th Oct 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15th Oct 2024PUBLISHED FOR OPPOSITION
25th Sep 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09th Sep 2024ASSIGNED TO LIE
09th Sep 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
09th Sep 2024TEAS/EMAIL CORRESPONDENCE ENTERED
09th Sep 2024APPROVED FOR PUB - PRINCIPAL REGISTER
15th Apr 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED